Effects of Melatonin Receptor 1B Gene Variation on Glucose Control in Population from Bosnia and Herzegovina

Abstract

Common variants in MTNR1B, encoding melatonin receptor 1B, have been recently associated with impaired glucose homeostasis and an increased risk for developing Type 2 diabetes (T2D). In this study we investigated the association of MTNR1B variant rs10830963 with T2D and related quantitative traits in a population from Bosnia and Herzegovina (BH). A total number of 268 subjects were recruited in the study (162 T2D patients and 106 nondiabetic controls). Subjects were genotyped for MTNR1B rs10830963 SNP by using hydrolysis probes. Our data showed that the prevalence of the MTNR1B rs10830963 risk G-allele in BH population was 26%. Furthermore, we demonstrated a significant association of MTNR1B rs10830963 variant with fasting plasma glucose (FPG) levels in nondiabetic subjects. Under the additive genetic model, each variant G-allele was associated with an increased FPG levels of 0.29 mmol/L (95% CI 0.12, 0.46, p=0.001). Strikingly, our results also showed a significant association of this MTNR1B polymorphism with increased glycated hemoglobin (HbA1c) levels in nondiabetic subjects (p=0.040, additive genetic model). An association of the MTNR1B variant rs10830963 with T2D risk was not detected in our cohort. In conclusion, here we have demonstrated the association between the common MTNR1B rs10830963 variation and fasting plasma glucose levels in BH population. Furthermore, the influence of this polymorphism on the HbA1c levels was also shown in this study, further strengthening its role in blood glucose control.

Key words

type 2 diabetes - MTNR1B - HbA1c - glucose

• References

• 1 Lyssenko V, Nagorny CL, Erdos MR et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009; 41: 82-88
• 2 Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009; 41: 89-94
• 3 Bonnefond A, Clement N, Fawcett K et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 2012; 44: 297-301
• 4 Staiger H, Machicao F, Schafer SA et al. Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One 2008; 3: e3962
• 5 Ronn T, Wen J, Yang Z et al. A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia 2009; 52: 830-833
• 6 Sparso T, Bonnefond A, Andersson E et al. G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes 2009; 58: 1450-1456
• 7 Chambers JC, Zhang W, Zabaneh D et al. Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes 2009; 58: 2703-2708
• 8 Li C, Qiao B, Zhan Y et al. Association between Genetic Variations in MTNR1A and MTNR1B Genes and Gestational Diabetes Mellitus in Han Chinese Women. Gynecol Obstet Invest 2013; 76: 221-227
• 9 Huopio H, Cederberg H, Vangipurapu J et al. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol 2013; 169: 291-297
• 10 Mao H, Li Q, Gao S. Meta-analysis of the relationship between common type 2 diabetes risk gene variants with gestational diabetes mellitus. PLoS One 2012; 7: e45882
• 11 Liao S, Liu Y, Tan Y et al. Association of genetic variants of melatonin receptor 1B with gestational plasma glucose level and risk of glucose intolerance in pregnant Chinese women. PLoS One 2012; 7: e40113
• 12 Vlassi M, Gazouli M, Paltoglou G et al. The rs10830963 variant of melatonin receptor MTNR1B is associated with increased risk for gestational diabetes mellitus in a Greek population. Hormones (Athens) 2012; 11: 70-76
• 13 Florez JC, Jablonski KA, McAteer JB et al. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program. PLoS One 2012; 7: e44424
• 14 Dietrich K, Birkmeier S, Schleinitz D et al. Association and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of Sorbs from Germany. Diabet Med 2011; 28: 1373-1380
• 15 Hu C, Zhang R, Wang C et al. Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion. PLoS One 2010; 5: e11761
• 16 Mussig K, Staiger H, Machicao F et al. Genetic variants in MTNR1B affecting insulin secretion. Ann Med 2010; 42: 387-393
• 17 Stancakova A, Kuulasmaa T, Paananen J et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes 2009; 58: 2129-2136
• 18 Langenberg C, Pascoe L, Mari A et al. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia 2009; 52: 1537-1542
• 19 Xia Q, Chen ZX, Wang YC et al. Association between the melatonin receptor 1B gene polymorphism on the risk of type 2 diabetes, impaired glucose regulation: a meta-analysis. PLoS One 2012; 7: e50107
• 20 Andersson EA, Holst B, Sparso T et al. MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans. Diabetes 2010; 59: 1539-1548
• 21 Been LF, Hatfield JL, Shankar A et al. A low frequency variant within the GWAS locus of MTNR1B affects fasting glucose concentrations: genetic risk is modulated by obesity. Nutr Metab Cardiovasc Dis 2012; 22: 944-951
• 22 Prokopenko I, Langenberg C, Florez JC et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009; 41: 77-81
• 23 Reinehr T, Scherag A, Wang HJ et al. Relationship between MTNR1B (melatonin receptor 1B gene) polymorphism rs10830963 and glucose levels in overweight children and adolescents. Pediatr Diabetes 2011; 12: 435-441
• 24 Tam CH, Ho JS, Wang Y et al. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects. PLoS One 2010; 5: e11428
• 25 Liu C, Wu Y, Li H et al. MTNR1B rs10830963 is associated with fasting plasma glucose, HbA1C and impaired beta-cell function in Chinese Hans from Shanghai. BMC Med Genet 2010; 11: 59
• 26 Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
• 27 Wang H, Liu L, Zhao J et al. Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk. PLoS One 2013; 8: e67665
• 28 Jonsson A, Ladenvall C, Ahluwalia TS et al. Effects of common genetic variants associated with type 2 diabetes and glycemic traits on alpha- and beta-cell function and insulin action in humans. Diabetes 2013; 62: 2978-2983
• 29 Soranzo N, Sanna S, Wheeler E et al. Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes 2010; 59: 3229-3239
• 30 Muhlbauer E, Albrecht E, Hofmann K et al. Melatonin inhibits insulin secretion in rat insulinoma beta-cells (INS-1) heterologously expressing the human melatonin receptor isoform MT2. J Pineal Res 2011; 51: 361-372
• 31 Ensembl release 74 [Internet] 2013 Dec [cited 2014 Feb 25]. Available from: http://www.ensembl.org/Homo_sapiens/Variation/Phenotype?db=core;r=11:92708210-92709210;v=rs10830963;vdb = variation;vf=7183663